IVIG for Guillain-Barré Syndrome from Japan
Intravenous immunoglobulin pooled from thousands of donors, used therapeutically for Guillain-Barré and other neuropathies. Falls under HTS 3002.12.0090 as modified blood fraction immunological product. Bioprocessing includes pathogen reduction for safety.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Pool donor serology and IgG subclass profiles in import dossier